Top Markets
#1 Akedo Akedo +62.25%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +50.06%
#4 Velvet Velvet +40.81%
#5 Black Phoenix Black Phoenix +34.48%
#6 Ο„emplar Ο„emplar +27.84%
#7 Ribbita by Virtuals Ribbita by Virtuals +20.04%
#8 Not in Employment, Education, or Training Not in Employment, Education, or Training +18.68%
#9 Bitway Bitway +17.34%
#10 Cap Cap +16.41%
Coin of the day
Akedo Akedo
Settings
Language
ENGLISH
Currency
USD
Theme
Geffen Residence & Renewal Ltd Geffen Residence & Renewal Ltd

Geffen Residence & Renewal Ltd

GEFR
Rank in Stocks #38275
Geffen Residence & Renewal Ltd, previously known as Cannomed Medical Cannabis... Geffen Residence & Renewal Ltd, previously known as Cannomed Medical Cannabis Industries Ltd, is a company with a dual focus based in Tel Aviv-Yafo, Israel, established in 1999. It plays a significant role in the Israeli medical cannabis market, overseeing the growth, manufacturing, storage, distribution, and retail of these products. Additionally, the company operates a chain of pharmacies that offer a wide array of merchandise. These retail outlets provide personal care items, cosmetics, and various convenience goods. Their pharmaceutical offerings include prescription and over-the-counter medications, alongside natural health products, vitamins, and supplements. The pharmacies also stock first-aid supplies like plasters and bandages, as well as health monitoring devices such as thermometers and humidifiers.
Share Price
$0.26456612
Market Cap
$1.09M
Change (1 day)
1.24%
Change (1 year)
13.83%
Country
IL
Trade Geffen Residence & Renewal Ltd (GEFR)

Category

Healthcare
Revenue for Geffen Residence & Renewal Ltd (GEFR)
Revenue in Aug 2026 TTM: 0
According to Geffen Residence & Renewal Ltd latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Geffen Residence & Renewal Ltd from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B -
BE